Fuso Pharma Appeals 7.47 Billion Yen Patent Ruling to Japan's Supreme Court

Published on 09/06/2025 at 03:04

MT Newswires

This article is reserved for members

Unlock the article: REGISTER NOW!

100% Free Registration

Already a customer? Log In

Latest news about Fuso Pharmaceutical Industries,Ltd.

Fuso Pharmaceutical Industries, Ltd. Announces Executive Changes	06-25	CI
Fuso Pharma Appeals 7.47 Billion Yen Patent Ruling to Japan's Supreme Court	06-09	MT
Fuso Pharmaceutical Ordered to Pay 7.47 Billion Yen in Patent Case Over Nalfurafine Tablets	05-28	MT
Fuso Pharmaceutical Industries,Ltd. Provides Non-Consolidated Earnings Guidance for the First Half and Full Fiscal Year Ending March 31, 2026	05-09	CI
Tranche Update on Fuso Pharmaceutical Industries,Ltd.'s Equity Buyback Plan announced on September 5, 2023.	06/09/23	CI
Fuso Pharmaceutical Industries,Ltd.'s Equity Buyback announced on September 5, 2023, has closed with	05/09/23	CI
Fuso Pharmaceutical Industries,Ltd. announces an Equity Buyback for 340,000 shares, representing 3.88% for ¥735 million.	05/09/23	CI
Fuso Pharmaceutical Industries,Ltd. authorizes a Buyback Plan.	04/09/23	CI
Fuso Pharmaceutical Industries,Ltd.(TSE:4538) dropped from S&P Global BMI Index	19/09/22	CI
Fuso Pharmaceutical Industries,Ltd.(TSE:4538) added to S&P Global BMI Index	20/09/21	CI
Fuso Pharmaceutical Industries,Ltd.(TSE:4538) dropped from S&P Global BMI Index	18/09/17	CI
Tranche Update on Fuso Pharmaceutical Industries,Ltd.'s Equity Buyback Plan announced on September 4, 2017.	05/09/17	CI
Fuso Pharmaceutical Industries,Ltd.'s Equity Buyback announced on September 4, 2017 has expired with 154,100 shares, representing 1.72% for ¥421.62 million.	04/09/17	CI
Fuso Pharmaceutical Industries,Ltd. announces an Equity Buyback for 200,000 shares, representing 2.24% for ¥547.2 million.	04/09/17	CI
Fuso Pharmaceutical Industries,Ltd. authorizes a Buyback Plan.	03/09/17	CI
Fuso Pharmaceutical Industries,Ltd. authorizes a Buyback Plan.	23/10/16	CI
Fuso Pharmaceutical Industries,Ltd. announces an Equity Buyback for 866 shares, for ¥2.3 million.	23/10/16	CI
Fuso Pharmaceutical Industries,Ltd.'s Equity Buyback announced on October 24, 2016 has expired.	23/10/16	CI
Fuso Pharmaceutical Industries,Ltd.'s Equity Buyback announced on August 29, 2016 has expired with 1,050,000 shares for ¥271.95 million.	29/08/16	CI
Tranche Update on Fuso Pharmaceutical Industries,Ltd.'s Equity Buyback Plan announced on August 29, 2016.	29/08/16	CI
Fuso Pharmaceutical Industries,Ltd. authorizes a Buyback Plan.	28/08/16	CI
Fuso Pharmaceutical Industries,Ltd. announces an Equity Buyback for 1,300,000 shares, representing 1.44% for ¥336.7 million.	28/08/16	CI
JA Mitsui Leasing, Ltd. cancelled the acquisition of Kyobashi Parking Lot of Fuso Pharmaceutical Industries,Ltd..	21/11/13	CI
JA Mitsui Leasing, Ltd. entered into an agreement to acquire Kyobashi Parking Lot of Fuso Pharmaceutical Industries,Ltd. for ¥4 billion.	21/11/12	CI